On February 26, HF 555 passed the Senate with a unanimous vote (46-0). It returns to the House for concurrence with the Senate amendments. 

Also in Iowa, the Department of Health and Human Services, Iowa Medicaid posted the following:   

Finally in Iowa, the Board of Pharmacy adopted and filed ARC 7617C to amend Chapter 10, “Controlled Substances”. The amendment temporarily places five substances (novel psychoactive substances of the benzodiazepine class, also known as “designer benzodiazepines”) to Schedule I of the Iowa CSA (Controlled Substances Act) in response to similar action taken by the federal Drug Enforcement Administration. The amendment is effective March 13.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.